Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Apr 28;22(1):40.
doi: 10.1186/2008-2231-22-40.

Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study

Free PMC article
Randomized Controlled Trial

Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study

Elham Akhtari et al. Daru. .
Free PMC article


Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test.

Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p < 0.001), desire (p < 0.001), arousal (p = 0.037), lubrication (p < 0.001), satisfaction (p < 0.001) and pain (p = 0.041) domains of FSFI. Frequency of side effects was similar between the two groups.

Conclusions: Tribulus terrestris may safely and effectively improve desire in women with hypoactive sexual desire disorder. Further investigation of Tribulus terrestris in women is warranted.


Figure 1
Figure 1
Flow chart indicating subject enrolment, group allocation and analysis according to CONSORT guidelines.

Similar articles

Cited by 9 articles


    1. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970–978. doi: 10.1097/AOG.0b013e3181898cdb. - DOI - PubMed
    1. Leiblum SR, KKoochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive Sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS) Menopause. 2006;13(1):46–56. doi: 10.1097/01.gme.0000172596.76272.06. - DOI - PubMed
    1. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of western European women. J Sex Med. 2006;3(2):212–22. doi: 10.1111/j.1743-6109.2006.00215.x. - DOI - PubMed
    1. Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the “true” prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med. 2008;5(4):777–778. doi: 10.1111/j.1743-6109.2007.00768.x. - DOI - PubMed
    1. Safarinejad MR. Female sexual dysfunction in population based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18(4):382–395. doi: 10.1038/sj.ijir.3901440. - DOI - PubMed

Publication types